Ozempic (semaglutide) and Trulicity (dulaglutide) are prescription drugs used for people with type 2 diabetes and certain other conditions. Both drugs are injected under the skin. Ozempic and ...

Trulicity (dulaglutide) is another medication used to manage blood sugar levels in people with type 2 diabetes. It’s in the same group of drugs as Victoza, called GLP-1 agonists. Trulicity and ...

New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Trulicity (diabetes): from $54.04 to $128.43 per month. Xarelto (blood clots): from $46.54 to $94.50 per month. Ozempic (diabetes/weight loss): from $56.95 to $135.43 per month. Patients in ...

Two other GLP-1 receptor agonist products -- dulaglutide (Trulicity) and liraglutide (Victoza, Saxenda) -- still remain in shortage, the FDA noted.